NCT03699631: A trial that was reported late by Medical College of Wisconsin
This trial has reported, although it was 26 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03699631 |
|---|---|
| Title | PROACTIVE: Prevention of Acute and Chronic GVHD Using TocIlizumab in Combination With Standard GVHD Prophylaxis After allogEneic Transplantation |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 6, 2018 |
| Completion date | March 2, 2022 |
| Required reporting date | March 2, 2023, midnight |
| Actual reporting date | March 28, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 26 |